Camlin Fine Sciences credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
668668646658780
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
515515454564680
0.67×0.67×0.74×0.77×0.95×
0.51×0.51×0.52×0.66×0.83×
6.25×6.25×3.10×8.90×3.80×
5.99×4.82×2.18×7.63×3.31×
0.49×0.49×1.44×−0.08×2.44×
40.0%40.0%42.5%43.4%48.6%
As filed — company-reported covenants
——72.00×——
——1.00×——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals
₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,581 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt779.6657.7645.6668.1668.1
Net Debt680.4564.1453.8514.9514.9
Total Debt/Equity0.950.770.740.670.67
Net Debt/Equity0.830.660.520.510.51
Total Debt/EBITDA3.808.903.106.256.25
Net Debt/EBITDA3.317.632.184.825.99
Interest Coverage (EBIT/Interest)2.44-0.081.440.490.49
Total Debt/Total Capital %48.6143.4242.4640.0340.03
As Filed — company-reported covenants
Debt/Equity (as filed)——72.00——
Debt Service Coverage (as filed)——1.00——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.